Identification of populations likely to benefit from pharmacogenomic testing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of populations likely to benefit from pharmacogenomic testing

Published:2020-03-23 Issue:5 Volume:30 Page:91-95
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Heise Craig William,Gallo Tyler,Curry Steven C.,Woosley Raymond L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference11 articles.

1. CPIC: Clinical Pharmacogenetics Implementation Consortium of the pharmacogenomics research network.;Saito;Clin Pharmacol Ther,2016

2. Pharmacogenetic information in clinical guidelines: the European perspective.;Swen;Clin Pharmacol Ther,2018

3. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.;Trivedi;Am J Psychiatry,2006

4. Projected prevalence of actionable pharmacogenetic variants and level A drugs prescribed among US veterans health administration pharmacy users.;Chanfreau-Coffinier;JAMA Netw Open,2019

5. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.;Dunnenberger;Annu Rev Pharmacol Toxicol,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies;The Pharmacogenomics Journal;2024-01-17

2. Cardiovascular pharmacogenomics – Molecular basis of protective and adverse drug response;Genomic and Molecular Cardiovascular Medicine;2024

3. Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database;Journal of Personalized Medicine;2023-11-03

4. Patient understanding of pharmacogenomic test results in clinical care;Patient Education and Counseling;2023-10

5. Novel biomarkers for drug-induced liver injury;Clinical Toxicology;2023-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3